Rodolphe THIEBAUT, MD, PhD
University Hospital, Bordeaux
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rodolphe THIEBAUT, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:04 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03078426 · Lung MRI in the Management of Idiopathic Pulmonary FibrosisUniversity Hospital, Bordeaux · completed · Idiopathic Pulmonary Fibrosis
- Ph4NCT02328963 · Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine AUniversity Hospital, Bordeaux · completed · Transplantation Infection, Cytomegalovirus Infection · study chair
- N/ANCT02185677 · Cognitive and Behavioral Dysexecutive Syndrome in Multiple System AtrophyUniversity Hospital, Bordeaux · completed · Multiple System Atrophy · study chair
- N/ANCT01992029 · Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral SclerosisUniversity Hospital, Bordeaux · terminated · Amyotrophic Lateral Sclerosis, ALS · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.